Home

Redmile Group reported a 9.9% stake in ADC Therapeutics ADCT · 12,692,841 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
9.9%
Last report
12.7% · filed 26/02/17
Shares held
12,692,841 sh
Class
Common Shares, par value CHF 0.08 per share
Event date
26/04/06
Filed
26/04/06

9.9% stake · −2.8pp from the last report

Stake
9.9%
Last report
12.7%
Since last report
−2.8pp

ADC Therapeutics trades, last 26 weeks

What else happened in ADC Therapeutics around then

Filed or reported within 30 days of the trade day · 03/07~05/06

Redmile Group's other 5% stake reports

  • Redmile Group

    5% stakeElectra Therapeutics

    8.7% stake

    Filed 09/28

  • Redmile Group

    5% stakeNurix Therapeutics

    8.1% stake

    Filed 08/14

  • Redmile Group

    5% stakeScholar Rock Holding

    3.6% stake

    Filed 08/14

  • Redmile Group

    5% stakeAtara Biotherapeutics

    9.9% stake

    Filed 07/24

  • Redmile Group

    5% stakeShattuck Labs

    9.9% stake

    Filed 07/17

Redmile Group reported a 9.9% stake in ADC Therapeutics ADCT · 12,692,841 sh · amendment · passive holder | Whalegun